Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

Condition:   Fanconi Anemia Complementation Group A Intervention:   Biological: RP-L102 Sponsor:   Rocket Pharmaceuticals Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials